Drugs 2 Flashcards
Amantadine
Anti-influenza drug
MOA=uncoating agent
Widespread resistance, so rarely used
Amphotericin B
Amphipathic macrolide that binds to ergosterol in fungal cell membrane, forming pores that allow ions to leak out of cell
Broad anti-fungal spectrum
Given for life threatening systemic infections
Insoluble in water, so suspended in deoxycholate
Poorly absorbed by GI tract–>only given orally if problem is in GI tract
Intrinsic resistance in candida lusitaniae and pseudallescheria boydii
Causes bad side effects
Acute/infusion related toxicity=fever, chills, hypotension
Slower toxicity=kidney damage
Imidazoles
2N azoles
Older, less potent
Ketoconazole, clotrimazole, miconazole
Dasabuvir
HCV RNA polymerase inhibitor
In Viekira Pak
Triazoles
3N azoles
Itraconazole, voriconazole, and fluconazole
Griseofulvin
Anti-fungal that interferes with microtubules
Itraconazole
Most potent triazole
Wide spectrum of action
Widely distributed
Lipid soluble; absorption increased by gastric acid
Toxicity=GI distress, teratogenic
Drug interactions: H2 and proton pump blockers decrease gastric acidity, metabolized by P450 enzymes
5-Fluorocytosine
Anti-fungal nucleoside analog that inhibits DNA and RNA synthesis
Soluble in water so can be taken orally with rapid absorption from GI tract
Water soluble–>taken orally and easily absorbed in GI tract
Narrow spectrum
Given in drug combo to avoid resistance
Adverse effects: decrease function of bone marrow, rash, GI effects, renal toxicity
Oseltamivir
Anti-influenza drug
MOA=neuraminidase inhibitor
Capsofungin
Echinocandins that inhibit beta-glucan synthesis
Fluconazole
Triazole
As compared to itraconazole, absorption is not impaired by stomach acid, it has fewer P450 drug interactions, and is widely distributed to include CNS
Echinocandins
Anti-fungals that blocks cell wall synthesis by inhibiting beta (1,3)-glucan synthase
Caspofungin
Used for candida, invasive aspergillosis that is resistant to amphotericin B
Minor adverse effects
Resistance from mutation in FKS1 (gene encoding for beta 1,3 glucan synthase)
Zanamivir
Anti-influenza drug
MOA=neuraminidase inhibitor
Rimantidine
Anti-influenza drug
MOA=uncoating agent
Widespread resistance, so rarely used
Acyclovir
Nucleoside analog for herpes and CMV
Guanosine derivative
First phosphorylation by the viral enzyme; second and third by host enzymes
Outcompetes guanosine and is a chain terminator
Oral, topical, IV that is well tolerated
Resistance from HSV thymidine kinase mutation
Terbinafine
Inhibits ergosterol biosynthesis by blocking squalene epoxidase
Synthetic allylamine
Used systemically or topically
Accumulates in skin, nail, and fat
Targets tinea
Must be used continuously
Synergistic with triazoles
Peramivir
Anti-influenza drug
MOA=neuraminidase inhibitor
Famciclovir
Topical nucleoside analog for herpes, CMS
Guanosine derivative that does not cause chain termination
Miltefosine
Drug used for leishmaniasis
Inhibits cytochrome c oxidase activity needed for promastigotes and amastigotes, causing apoptosis
Ganciclovir
Topical nucleoside analog for herpes, CMS
Guanosine derivative that causes chain termination
Teratogenic
Amantadine
Viral entry inhibitor of influenza (adamantanes)
Binds M2 protein on virus to inhibit unsheathing
Resistance when M2 is mutated
Excreted unmetabolized
Rimantadine
Viral entry inhibitor of influenza (adamantanes)
Binds M2 protein on virus to inhibit unsheathing
Resistance when M2 is mutated
Excreted as metabolized form
Voriconazole
Newest triazole
Given for aspergillus fumigatus
Zanamivir
Neuramidase inhibitor for influenza
Sialic acid transition state analog; prevent viral exit
Inhaled
Ribavirin
Nucleoside analog as first line treatment for HCV
Guanosine analog that inhibits RNA synthesis, capping, and replication
Side effects: psychiatric, teratogen
Ombitasivir
HCV NS5A inhibitor
In Viekira Pak
Foscarnet
Aka foscavir
Binds DNA pol, RNA pol, and HIV RT to inhibit cleavage
Resistance in strands with mutations in DNA pol, but good for strains resistant to ganciclovir and cidofovir
Administered via IV
Peramivir
Neuramidase inhibitor for influenza
Sialic acid transition state analog; prevent viral exit
Administered as a single IV dose
Interferons
Given for HCV and HBV as first line treatment
Activate JAK-STAT pathway to initiate human antiviral response which inhibits viral transcription, translation, protein processing, and maturation
MANY adverse side effects, so often have to stop taking
Interferes with P450 metabolism of other drugs
Administered via IV with polyethylene glycol (PEG) to increase half life
Entecavir
Nucleoside analog as first line treatment for HBV
Guanosine analog that causes steric hindrance in helix, stopping replication
3’ hydroxyl allows for additional bases to be added before termination
Little resistance, little side effects
Tenofovir
Nucleotide analog used as first line treatment for HBV and HIV
Inhibits reverse transcriptase
Adenosine analog that already has first phosphate to overcome rate limiting step
Chain terminator
Little resistance
Side effects: nephrotoxicity and decrease in bone mineral density
Truvada
Emtricitabine and tenofovir
Viral entry inhibitors for influenza
-adine
Amantadine
Rimantadine
Cidofovir
Nucleoside analog for herpes, CMV
Phosphorylated twice, both times by host kinases
Resistance due to mutations in viral DNA pol
Cross resistance with ganciclovir
Dose dependent nephrotoxicity made worse by probenecid (blocks tubular transport of cidovir so it is not cleared; given to treat gout)
Sofosbuvir
Nucleotide analog used as first line treatment for HCV
Uridine chain terminator
Prodrug-carries first phosphate to overcome RSL
Daily pill
Little resistance and little side effects
Oseltamivir
Neuramidase inhibitor for influenza
Sialic acid transition state analog; prevent viral exit
Aka tamiflu
Oral administration
Ledipasvir
HCV NS5A inhibitor
Binds NS5A tightly
Paritaprevir
HCV protease inhibitor
In Viekira Pak
Simiprevir
HCV protease inhibitor
Grazoprevir
HCV protease inhibitor
Azoles
Fungistatic
Inhibit ergosterol synthesis by blocking the third step, ERG11 gene
Cause accumulation of toxic membrane methylsterols (more deleterious effect)
Adverse effects: minor GI problems, some liver enzyme abnormality
Resistance mechanisms: efflux pump, change in expression of enzyme to reduce affinity of azole or require more azole, and mutation in ERG3 so no longer make cytotoxic chemicals
Interacts with P450 drugs
Elbasvir
HCV NS5A inhibitor
Viekira Pak
Combination for HCV
Includes
Two pills of paritaprevir (protease), ritonavir (booster for paritaprevir), and ombitasvir (NS5A)
One pill of dasabuvir (RNA pol inhibitor)
Maraviroc
HIV fusion inhibitor
Binds CCR5 to mask it from HIV
Metabolized by p450s
Resistance due to emergence of strains that use CXCR4 to get into CD4+ cells
Enfuvirtide
HIV fusion inhibitor
Targets p41 on HIV virus
HIV integrase inhibitors
-gravir
Raltegravir
Elvitegravir
Dolutegravir
Emtricitabine
HIV nucleoside analog with long half life
Inhibits reverse transcriptase
Etravirine
Non-nucleotide reverse transcriptase inhibitor
Strategic flexibility allows it to accommodate for mutations in the active site
Reserved for resistant strands
Efavirenz
Non-nucleoside reverse transcriptase inhibitor
Binds to site adjacent to active site on reverse transcriptase to cause conformational change
Raltegravir
HIV integrase inhibitor
Binds Mg2+ in active site of Integrase-DNA complex to displace 3’OH
First line therapy; very potent
Atazanavir
HIV protease inhibitor
Once daily with fewer lipid distribution side effects
Elvitegravir
HIV integrase inhibitor
Binds Mg2+ in active site of integrase-DNA complex to displace 3’OH
Use cobicistat as a booster
Ritonavir
HIV protease inhibitor
Dolutegravir
HIV integrase inhibitor
Part of Triumeq
HIV Protease Inhibitors
-avir
Atazanavir
Darunavir
Ritonavir
HCV protease inhibitors
-previr
Simiprevir
Paritaprevir
Grazoprevir
Darunavir
HIV protease inhibitor
Take twice orally
HCV NS5a inhibitors
-asvirs
Ledispasvir
Daclatasvir
Elbasvir
Ombitasvir
Viral exit inhibitors of influenza
-amivir
Zanamivir
Oseltamivir
Peramivir
Daclatasvir
HCV NS5A inhibitor
Very potent